Investor Relations Contact Investor Relations Get in touch Investor Relations Email info@novointegrated.com Phone (888) 512-1195 People Chris David President/COO Novo Integrated Sciences Transfer Agent Email info@pacificstocktransfer.com info@pacificstocktransfer.com Phone (702) 361-3033 Voice: (702) 361-3033 Fax: (702) 433-1979 Write Pacific Stock Transfer Company 6725 Via Austi Pkwy, Suite 300 Las Vegas, Nevada 89119 Stay connected with Investor news Follow us and stay up to date on what's happening at Novo Integrated Sciences CAUTION CONCERNING FORWARD LOOKING STATEMENTS Novo Integrated Sciences's Investor Relations website at www.novointegrated.com/investors and our corporate blog at novointegrated.com/newsroom as well as Novo Integrated Sciences's social media accounts, contain a significant amount of information about the company, including financial and other information for investors. Novo Integrated Sciences encourages investors to visit these websites from time to time, as information is updated and new information is posted. ROBERT MATTACCHIONE CEO, Novo Integrated Sciences Inc Follow Robert on LinkedIn CHRIS DAVID President, Novo Integrated Sciences Inc Follow Chris on LinkedIn Subscribe for Company Updates Email* Submit Follow Us Company Novo Integrated Sciences is a U.S. based parent company, publicly-traded on the Nasdaq Capital Markets (Nasdaq:NVOS), with both U.S. and Canadian based wholly owned subsidiaries. Currently, the Company’s revenue is generated solely by services and products provided by NHL’s team of multidisciplinary primary care clinicians and practitioners in Canada. Site Map Investors About Newsroom SEC Reports Careers Contact Address 11120 NE 2nd Street, Suite 100 Bellevue, Washington 98004 USA (888) 512-1195 info@novointegrated.com Disclaimer Privacy Copyright © 2000 - 2021 Novo Integrated Sciences Inc. All rights reserved

Subscribe for Company Updates Email* Submit Follow Us Company Novo Integrated Sciences is a U.S. based parent company, publicly-traded on the Nasdaq Capital Markets (Nasdaq:NVOS), with both U.S. and Canadian based wholly owned subsidiaries. Currently, the Company’s revenue is generated solely by services and products provided by NHL’s team of multidisciplinary primary care clinicians and practitioners in Canada. Site Map Investors About Newsroom SEC Reports Careers Contact Address 11120 NE 2nd Street, Suite 100 Bellevue, Washington 98004 USA (888) 512-1195 info@novointegrated.com Disclaimer Privacy Copyright © 2000 - 2021 Novo Integrated Sciences Inc. All rights reserved